Functional SNP -1562C/T in the promoter region of MMP9 and recurrent early pregnancy loss

Reproductive BioMedicine Online

Volumn 24, Issue 1, 2012, Pages 61-65

  Singh, Kiran ^a   Nair, Rohini R ^a   Khanna, Anuradha ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

1562C T SNP; angiogenesis; decidualization; endometrium; matrix metalloproteinase; recurrent early pregnancy loss

Indexed keywords

GELATINASE B;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREGNANCY DISORDER; RECURRENT EARLY PREGNANCY LOSS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ABORTION, HABITUAL; ALLELES; CASE-CONTROL STUDIES; EMBRYO LOSS; FEMALE; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 9; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROMOTER REGIONS, GENETIC;

EID: 84855355695     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2011.09.007     Document Type: Article

References (28)

1. Aplin, J.D., Charlton, A.K., Ayad, S., 1988. An immunohistochemical study of human extracellular matrix during the menstrual cycle and first trimester of pregnancy. Cell Tissue Res. 253, 231-240.
2. Burton, G.J., Jauniaux, E., Watson, A.L., 1999. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am. J. Obstet. Gynecol. 181, 718-724. (Pubitemid 29453538)
3. Campbell, S., Rowe, J., Jackson, C.J., Gallery, E.D., 2003. In vitro migration of cytotrophoblasts through a decidual endothelial cell monolayer: the role of matrix metalloproteinases. Placenta 24, 306-315. (Pubitemid 37184748)
4. Coolman, M., de Maat, M., Van Heerde, W.L., 2007. Matrix metalloproteinase-9gene -1562C/T polymorphism mitigates preeclampsia. Placenta 28, 709-713. (Pubitemid 46852295)
5. Curry Jr., T.E., Osteen, K.G., 2003. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr. Rev. 24, 428-465. (Pubitemid 37056240)
6. Gremlich, S., Nguyen, D., Reymondin, D., Hohlfeld, P., Vial, Y., Witkin, S.S., Gerber, S., 2007. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk. J. Reprod. Immunol. 74, 143-151. (Pubitemid 46679071)
7. Kearns, M., Lala, P.K., 1983. Life history of decidual cells: a review. Am. J. Reprod. Immunol. 3, 78-82. (Pubitemid 13120556)
8. Khokha, R., Denhart, D.T., 1989. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metastasis 9, 391-405. (Pubitemid 20050866)
9. Kim, J.S., Park, H.Y., Kwon, J.H., Im, E.K., Choi, D., Jang, D., Cho, S.Y., 2002. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Yonsei Med. J. 43, 473-481. (Pubitemid 35012393)
10. Kislaus, L.L., Herr, J.C., Little, C.D., 1987. Immunolocalization of extracellular matrix proteins and collagen synthesis in first trimester human decidua. Anat. Rec. 218, 402-415. (Pubitemid 17123465)
11. Laird, S.M., Tuckerman, E.M., Cork, B.A., Linjawi, S., Blakemore, A.I.F., Li, T.C., 2003. A review of immune cells and molecules in women with recurrent miscarriage. Hum. Reprod. Update 9, 163-174. (Pubitemid 36582604)
12. Malik, S., Day, K., Perrault, I., Charnock-Jones, D.S., Smith, K.S., 2006. Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-a in menstrual endometrium and effluent in women with menorrhagia. Hum. Reprod. 21, 2158-2166. (Pubitemid 44288097)
13. Noyes, R.W., Hertig, A.T., Rock, J., 1950. Dating the endometrial biopsy. Fertil. Steril. 1, 3-25.
14. Palei, Ana C.T., Sandrim, V.C., Duarte, G., Cavalli, R.C., Gerlach, R.F., Tanus-Santos, J.E., 2010. Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension. Clin. Chim. Acta 411, 874-877.
15. Peters, D.G., Kassam, A., St. Jean, P.L., Yonas, H., Ferrell, R.E., 1999. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke 30, 2612-2616.
16. Pijnenborg, R., Bland, J.M., Robertson, W.B., Brosens, I., 1983. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 4, 397-413. (Pubitemid 13005635)
17. Reynolds, L.P., Redmer, D.A., 1995. Utero-placental vascular development and placental function. J. Anim. Sci. 73, 1839-1851.
18. Rollin, J., Regina, S., Vourc'h, P., Iochmann, S., Blechet, C., Reverdiau, P., Gruel, Y., 2007. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of nonsmall cell lung cancer. Lung Cancer 56, 273-280. (Pubitemid 46591988)
19. Salamonsen, L.A., Dimitriadis, E., Jones, R.L., Nie, G., 2003. Complex regulation of decidualisation: a role for cytokines and proteases - a review. Placenta 24, S76-S85. (Pubitemid 37184739)
20. Sfar, S., Saad, H., Mosbah, F., Gabbouj, S., Chouchane, L., 2008. TSP1 and MMP9 genetic variants in sporadic prostate cancer. Cancer Genet. Cytogenet. 172, z38-z44.
21. Shimajiri, S., Arima, N., Tanimoto, A., Murata, Y., Hamada, T., Wang, K.Y., Sasaguri, Y., 1999. Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett. 455, 70-74. (Pubitemid 29322784)
22. Skrzypczak, J., Wirstlein, P., Mikolajczyk1, M., Ludwikowski, G., Zak, T., 2007. TGF superfamily and MMP2, MMP9, TIMP1 genes expression in the endometrium of women with impaired reproduction. Folia Histochem. Cytobiol. 45, 143-148. (Pubitemid 351807774)
23. Smith, S.K., 2000. Angiogenesis and implantation. Hum. Reprod. 5, 59-66. (Pubitemid 32058475)
24. Sugimoto, M., Yoshida, S., Kennedy, S., Deguchi, M., Ohara, N., Maruo, T., 2006. Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. J. Soc. Gynecol. Investig. 13, 523-529. (Pubitemid 44528299)
25. Van den Steen, P.E., Dubois, B., Nelissen, I., Rudd, P.M., Dwek, R.A., Opdenakker, G., 2003. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. 37, 375-536.
26. Woo, M., Park, K., Nam, J., Kim, J.C., 2007. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J. Gastroenterol. Hepatol. 22, 1064-1070. (Pubitemid 47019841)
27. Xu, P., Wang, Y.L., Zhu, S.J., Luo, S.Y., Piao, Y.S., Zhuang, L.Z., 2000. Expression of matrix metalloproteinase-2, -9, and -14, tissue inhibitors of metalloproteinase-1, and matrix proteins in human placenta during the first trimester. Biol. Reprod. 62, 988-999.
28. Zhang, B., Ye, S., Herrmann, S.M., Eriksson, P., De, M.M., Evans, A., Arveiler, D., Luc, G., Cambien, F., Hamsten, A., Watkins, H., Henney, A.M., 1999. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99, 1788-1794. (Pubitemid 29181405)